SMAD3 and amyotrophic lateral sclerosis: Gonzalez et al. [6] showed that muscle from a mouse model of amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease, expressed increased amounts of TGF-β and Smad3, increased fibrosis, and induction of fibroadipogenic precursors.